We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

NYSE:ELV

Elevance Health (ELV)

NYSE • ELV • US0367521038

Ex-dividend 04 Dec · 1.72 USD (special)

434.18Last close

Market Closed

Ex-dividend 04 Dec · 1.72 USD (special)

Trading Signals

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 2.5% of free float is sold short, 3.7 days to cover, cost to borrow 0.52%.

Market Cap

93.8b USD | # 253 in US

Volume

1.18m shares | 482.38m USD

Shares Outstanding

216.06m

Free Float Shares

99.77% | 215.57m

DB:A58|

XTRA:A58|

LSE:0HG8|

BOVESPA:E1LV34|

BIT:1ANTM|

WBAG:ELV

News

ELV key data

Elevance Health (NYSE: ELV) has a market capitalization of $93.81B. Last close $434.18 (as of 2026-11-05); 52-week range $274.84 to $450.69. ORTEX data as of 2026-11-03: short interest is 2.45% of free float, 3.7 days to cover and the average cost to borrow is 0.52%.

ELV news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.